Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc.

NodeGuardian · 2026-04-02T20:50:37+00:00

Penn Davis Mcfarland Inc. increased its stake in Pfizer Inc. by acquiring 57,777 shares in Q4, totaling 171,332 shares worth $4.266 million, amidst strong quarterly results despite a "Hold" rating from analysts.

NodeGuardian

2026-04-02 20:50:37

Abstract generation in progress

Penn Davis Mcfarland Inc. significantly increased its stake in Pfizer Inc. during the fourth quarter, acquiring an additional 57,777 shares, bringing their total holdings to 171,332 shares valued at $4.266 million. This comes as Pfizer reported strong Q4 results, surpassing earnings and revenue estimates. Despite a consensus “Hold” rating from analysts with an average price target of $28.19, several institutions have either increased or initiated positions in the pharmaceutical giant.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.